1. Yu MH.(2002) Neoadjuvant chemotherapy for advanced ovarian cancer. The 2002 Annual Meeting of TAOG & Chien Tien Hsu Memorial Lectures, Taipei, ROC


2. Yu MH.(2003) Verruca carcinoma of uterine cervix. The 2003 Annual Meeting of TAOG & Chien Tien Hsu Memorial Lectures, Taipei, ROC


3. Yu MH, Roffler S.R., Lai HC, Chu TY. (2003) Topoisomerase-I Activity in Ovarian Cancers is a Predictor of Sensitivity to Topotecan Chemotherapy.? 2003 annual Meeting of? Chinese Medical Association –Taipei


4. Yu MH, Roffler S.R., Lai HC, Chu TY. (2004) Topoisomerase-I Activity in Ovarian Cancers is a Predictor of Sensitivity to Topotecan Chemotherapy.? 10th biennial international gynecologic cancer society meeting(IGCS). Edinburgh, Scotland